Preclinical Services Revvity With extensive expertise and advanced technology, we provide reliable preclinical oncology services and tailored solutions that help accelerate drug discovery in oncology and immuno oncology research. This is a powerful platform for integrating and promoting imaging workflows across various preclinical modalities. this solution enables the integration of all optical information into a single environment, utilizing advanced ai driven technology.
Comprehensive Preclinical Services Preclinical Cro Revvity “our living image synergy ai software marks a significant leap forward in preclinical imaging analysis,” said kevin quick, vp of platforms at revvity. 当社のpreclinicalサービスチームと連携することで、経験豊富な科学者のノウハウと、pin point™ 塩基編集技術、oncosignature™ およびimmusignature™化合物スクリーニングなどの先進的なプラットフォームをご活用いただけます。. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity offers a leading portfolio of automated cell counters, image cytometry systems, and cell counting reagents and consumables. advance your gene therapy research with revvity’s pre clinical development solutions tools for imaging, cell counting, organoids, and assay development.
Comprehensive Preclinical Services Preclinical Cro Revvity Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity offers a leading portfolio of automated cell counters, image cytometry systems, and cell counting reagents and consumables. advance your gene therapy research with revvity’s pre clinical development solutions tools for imaging, cell counting, organoids, and assay development. By combining intelligent automation with a unified analysis platform, revvity aims to help researchers uncover deeper biological insights, improve data reliability, and accelerate the development of new therapies. Revvity offers preclinical services for antibody therapeutics, including monoclonal, bispecific, and engineered formats to accelerate drug discovery. Discover how revvity's preclinical oncology services specializing in cell based assay can help answer your critical drug discovery questions in this comprehensive and interactive brochure. We’ve compiled a selection of recent publications that utilizes revvity’s preclinical services to enhance scientific research and progress drug discovery.
Comments are closed.